SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Care-plan review) — Theodore Roosevelt

PatientTheodore Roosevelt
Date of birth2002-10-27
IdentifiersMRN HR-NI012-SYN; SSN (made up) 000-12-6157
Document date2026-09-14
AuthorAmos Kettering, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-month asthma review after a summer exacerbation. [S]

History of Present Illness

Mr. Roosevelt returns for his six-month review. Six weeks ago he had a moderate exacerbation with a cold, treated at a same-day visit with five days of prednisone 40 mg. The nurse telephone check three days later found his peak flow back above 500 L/min. He was not seen in clinic within the week afterwards, as his plan advised, because the appointment was never booked. He recovered fully within ten days and returned to training after two weeks. Since then he has had no night waking, no daytime symptoms apart from before training, and peak flows of 580 to 610 L/min. He takes every maintenance dose. [S]

ElementDetail
Interval historyModerate exacerbation with a cold six weeks ago; five days of prednisone; full recovery
Post-exacerbation follow-upTelephone check at three days; no clinic review within one week
Reliever useOne inhalation before training; none otherwise
Home peak flow580 to 610 L/min
AdherenceFull
Exacerbations in the past 12 monthsTwo oral corticosteroid courses: one last winter before controller therapy and one six weeks ago

Review of Systems

SystemResultFinding
RespiratoryNegativeNo cough, wheeze, or night symptoms
ConstitutionalNegativeNo fever; energy back to normal
EndocrineNegativeNo thirst, sleep disturbance, or mood change after the prednisone course

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Albuterol 90 mcg/actuation inhaler, two inhalations as needed for wheeze (bought after an urgent care visit; used most days before intake)Two inhalations every 4 hours as neededRespiratory tract route2025-12-15 to 2026-03-09stoppedS
Budesonide-formoterol 160/4.5 mcg inhaler, two inhalations twice daily for maintenanceTwo inhalations twice daily, with a spacer, rinsing the mouth afterwardsRespiratory tract route2026-03-09activeS
Budesonide-formoterol 160/4.5 mcg inhaler, one inhalation as needed for symptoms and before exercise; no more than 12 inhalations a day in totalOne inhalation as needed, repeated after a few minutes if needed; maximum 12 inhalations a day including maintenance dosesRespiratory tract route2026-03-09activeS
Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning for 5 daysTwo tablets by mouth each morning for 5 daysOral route2026-08-03 to 2026-08-07completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-14Body height175cmS
2026-09-14Body weight73.2kgS
2026-09-14Body mass index (BMI) [Ratio]23.9kg/m2S
2026-09-14Systolic blood pressure116mm[Hg]S
2026-09-14Diastolic blood pressure72mm[Hg]S
2026-09-14Heart rate68/minS
2026-09-14Respiratory rate14/minS
2026-09-14Body temperature36.7CelS
2026-09-14Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-14Maximum expiratory gas flow Respiratory system airway by Peak flow meter590L/min80 percent or more of his personal best of 610 L/min (green zone)NormalS
2026-09-14Total score [ACT]21{score}S

Physical Exam

Vital signs recorded on 2026-09-14; see the Vital Signs section. [S]

SystemFinding
GeneralWell
MouthNo thrush
LungsClear
Inhaler techniqueCorrect with his own inhaler and spacer

Problems

ProblemClinical statusVerificationCodeProvenance
Moderate persistent asthma, uncontrolled at intake, with reversible airflow obstruction on spirometry; synthetic modern diagnosis linked to his documented lifelong asthmaactiveconfirmed J45.40S — Synthetic modern classification confirmed by spirometry; the historical asthma is D and its persistence into adulthood is R.
Myopia, both eyes, corrected with glasses since boyhoodactiveconfirmed H52.13S — Synthetic modern entry linked to his documented near-sightedness.
Moderate asthma exacerbation triggered by a viral cold, treated in the office with a five-day prednisone course; resolvedresolvedconfirmed J45.41S — Synthetic exacerbation at an unscheduled visit; viral infection is the most common trigger of asthma exacerbations. It does not echo a dated historical episode.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyAsthma Control TestEvery visitCompleted today21, well controlled
ExaminationPeak flowDaily or with symptoms for moderate to severe asthmaCompleted today590 L/min, green zone
ExaminationInhaler technique with his own deviceEvery visitCompleted todayCorrect
Medication safetyAdherence and reliever useEvery visitCompleted todayFull adherence; reliever before training only
SurveyExacerbation historyEvery visitCompleted todayOne oral corticosteroid course since starting controller therapy, six weeks ago, with a viral cold; no emergency visits or hospital stays
SurveyClinic review within one week of an exacerbationWithin 1 week of any exacerbationDeferredMissed: advised at the sick visit but never booked, a deviation from the protocol; only the day-three nurse telephone check took place. No harm resulted: he recovered fully, and today's control and peak flow are good. Corrective action: post-exacerbation reviews are now booked at the sick visit before the patient leaves
Self-managementWritten asthma action planEvery visit and after every exacerbationCompleted todayReviewed and updated after the exacerbation
Self-managementTrigger and exposure review, smoking and vaping statusEvery visitCompleted todayViral colds remain his main trigger; never smoker
SurveyStep-up or step-down assessmentEvery visitCompleted todayNo change: step-down deferred because of the recent exacerbation; step-up not needed with good control, adherence, and technique
ExaminationSpirometryAt diagnosis, 3 to 6 months after stabilization, then every 1 to 2 yearsUp to dateNormal three months ago; next in one to two years
ReferralBiologic candidacy assessmentOnly if severe and uncontrolled despite optimized Step 4 to 5 therapyNot indicatedOne exacerbation on controller therapy, with good control between; criteria for severe asthma not met
Medication safetyVaccination statusYearlyDueInfluenza vaccine planned at next month's preventive visit

Goal progress:

Guideline basis: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026)

Follow-up: Preventive visit next month. Asthma review in three months, or within one week of any exacerbation. Next scheduled visit 2026-10-19: periodic adult preventive visit. [S]